Current therapy of the failing heart.
暂无分享,去创建一个
[1] E. Sonnenblick,et al. Sustained Hemodynamic and Clinical Effects of a New Cardiotonic Agent, WIN 47203, in Patients with Severe Congestive Heart Failure , 1983, Circulation.
[2] K. Swedberg,et al. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). , 1988, The American journal of cardiology.
[3] J. Cohn,et al. New inotropic drugs for heart failure. , 1987, JAMA.
[4] J. Cohn,et al. Comparative Hemodynamic Effects of Inotropic and Vasodilator Drugs in Severe Heart Failure , 1977, Circulation.
[5] R. A. Johnson,et al. Heart failure in outpatients: a randomized trial of digoxin versus placebo. , 1982, The New England journal of medicine.
[6] E. Varnauskas,et al. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. , 1975, British heart journal.
[7] J. Cohn,et al. Sustained hemodynamic effects without tolerance during long-term isosorbide dinitrate treatment of chronic left ventricular failure. , 1980, The American journal of cardiology.
[8] M. Wilén,et al. Minoxidil in patients with chronic left heart failure: contrasting hemodynamic and clinical effects in a controlled trial. , 1984, Circulation.
[9] J. Cohn,et al. Acute and Long‐term Response to an Oral Converting‐enzyme Inhibitor, Captopril, in Congestive Heart Failure , 1980, Circulation.
[10] T. Rector. Patients' self-assessment of their congestive heart failure : Content, reliability, and validity of a new measure, the Minnesota Living with Heart Failure Questionnaire , 1987 .
[11] F. Tristani,et al. Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure. Results of a Veterans Administration Cooperative Study , 1987 .
[12] F. Tristani,et al. Veterans Administration Cooperative Study on Vasodilator Therapy of Heart Failure: influence of prerandomization variables on the reduction of mortality by treatment with hydralazine and isosorbide dinitrate. , 1987, Circulation.
[13] J. Cohn,et al. Role of the Renin-Angiotensin System in the Systemic Vasoconstriction of Chronic Congestive Heart Failure , 1978, Circulation.
[14] A. Moss,et al. Digitalis‐associated Cardiac Mortality After Myocardial Infarction , 1981, Circulation.
[15] J. Cohn,et al. Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside. , 1978, Chest.
[16] P. Poole‐Wilson,et al. Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. , 1987, British heart journal.
[17] D. Roden,et al. Effects of congestive heart failure on the pharmacokinetics and pharmacodynamics of antiarrhythmic agents. , 1986, The American journal of cardiology.
[18] J. Cohn,et al. Contrasting immediate and long-term effects of isosorbide dinitrate on exercise capacity in congestive heart failure. , 1980, The American journal of medicine.
[19] J. Cohn,et al. Treatment of refractory heart failure with infusion of nitroprusside. , 1974, The New England journal of medicine.
[20] J. Cohn,et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. , 1984, The New England journal of medicine.
[21] J. Parker,et al. Tolerance to isosorbide dinitrate: rate of development and reversal. , 1983, Circulation.
[22] J. Cohn,et al. Predicting survival for an individual with congestive heart failure using the plasma norepinephrine concentration. , 1987, American heart journal.
[23] J. Cohn,et al. Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. , 1982, The American journal of cardiology.
[24] A J LINZBACH,et al. Heart failure from the point of view of quantitative anatomy. , 1960, The American journal of cardiology.
[25] J. Cohn,et al. Hyponatraemia as a marker for high renin heart failure. , 1982, British heart journal.
[26] J. Cohn. Indications for digitalis therapy. A new look. , 1974, JAMA.
[27] K. Wasserman,et al. Determinants and detection of anaerobic threshold and consequences of exercise above it. , 1987, Circulation.
[28] P. Bower. Vasodilator therapy in congestive heart failure. , 1982, The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society.
[29] T. Levine,et al. Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure. , 1981, The American journal of cardiology.
[30] J. Cohn,et al. Hemodynamic and clinical response to enalapril, a long-acting converting-enzyme inhibitor, in patients with congestive heart failure. , 1984, Circulation.
[31] J. Cohn,et al. Persistent hemodynamic effects without long-term clinical benefits in response to oral piroximone (MDL 19,205) in patients with congestive heart failure. , 1986, Circulation.
[32] T. Levine,et al. Acute Hemodynamic Effects of Nitrendipine in Chronic Congestive Heart Failure , 1984, Journal of cardiovascular pharmacology.